Host: HEK293 cells • AA: 20-1,120 • Tag: C-terminal His • MW: 125 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CD171 Extracellular Domain (human, recombinant)

Item No. 44180

Product Insert (PDF)
Technical Information
Synonyms
  • CAML1
  • CD171
  • L1CAM
  • L1 Cell Adhesion Molecule
  • NCAML1
  • Neural Cell Adhesion Molecule L1
Purity
≥85% estimated by SDS-PAGE
Endotoxin Testing
<1.0 EU/μg, determined by the LAL endotoxin assay
Source
Recombinant human C-terminal His-tagged L1CAM expressed in HEK293 cells
Amino Acids
20-1,120
MW
125 kDa
Lyophilized from sterile PBS, pH 7.4
UniProt Accession №
P32004
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    L1 cell adhesion molecule (L1CAM), also known as CD171, is a transmembrane glycoprotein and member of the L1 family of neural adhesion proteins.1,2 It is composed of six immunoglobulin (Ig) domains, five fibronectin type III-like domains, a transmembrane domain, and a short C-terminal domain.1 L1CAM is found in central and peripheral neurons, oligodendrocytes, immune cells, and cancer cells.3 It can interact with other L1CAM receptors in a cis confirmation and bind receptors, such as reelin or integrins, on other cells in a trans confirmation.2,4 L1CAM is generally involved in cell-cell binding, neural signaling, and signal transduction through C-terminal interactions with ezrin and focal adhesion kinase (FAK).2 The extracellular domain of L1CAM can be cleaved by serine proteases and promotes angiogenesis, invasion and metastasis, and cell survival and proliferation in tumors.5 The residual intracellular C-terminal fragment can be translocated to the nucleus where it promotes formation of neurite outgrowth and induces neuron migration.2 Truncating or missense mutations in L1CAM are found in patients with L1 syndrome, a group of neonatal conditions characterized by intellectual disability, hydrocephaly, involuntary spasms, and adducted thumbs.4 Cayman's L1CAM/CD171 Extracellular Domain (human, recombinant) protein consists of 1,112 amino acids, has a calculated molecular weight of 125 kDa, and a predicted N-terminus of Ile20 after signal peptide cleavage. By SDS-PAGE, under reducing conditions, the apparent molecular mass of the protein is 160-200 kDa due to glycosylation.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Altevogt, P., Doberstein, K., and Fogel, M. L1CAM in human cancer. Int. J. Cancer. 138(7), 1565-1576 (2016).

    2. Stoyanova, I.I., and Lutz, D. Functional diversity of neuronal cell adhesion and recognition molecule L1CAM through proteolytic cleavage. Cells 11(19), 3085 (2022).

    3. Gomes, D.E., and Witwer, K.W. L1CAM-associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization. J. Extracell. Biol. 1(3), e35 (2022).

    4. Zhang, L. CRASH syndrome: Does it teach us about neurotrophic functions of cell adhesion molecules? Neuroscientist 16(4), 470-474 (2010).

    5. Kiefel, H., Bondong, S., Hazin, J., et alL1CAM: A major driver for tumor cell invasion and motility. Cell Adh. Migr. 6(4), 374-384 (2012).